ANRO: the cashflow

MyFinsight

For the quarter ending 2025-09-30, ANRO had -$9,769K decrease in cash & cash equivalents over the period. -$9,918K in free cash flow.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net loss	-14,181	-32,875
Stock-based compensation expense	2,189	3,973
Depreciation	504	-
Non-cashinterest expense related to term loan	192	362
Depreciation and amortization	-	340
Non-cashlease expense	195	382
Non-cash research and development license expense	0	0
Loss on disposal of assets	-114	-42
Change in other, net	112	124
Loss on extinguishment of debt	0	-681
Prepaid expenses and other assets	-628	1,183
Accounts payable	461	57
Accrued liabilities and other liabilities	208	-2,238
Net cash used in operating activities	-9,918	-30,335
Capital expenditures	0	24
Net cash used in investing activities	0	-24
Proceeds from issuance of common stock from initial public offering	0	0
Payments on issuance costs-IPO	0	0
Payments on issuance cost from registration statement	0	556
Proceeds from issuance of term loan, net	0	19,688
Repayment of former term loan	0	10,213
Payment of loan financing cost	0	127
Payments on issuance costs-Series CPreferred Stock Financing	0	0
Proceeds from exercise of stock options	153	198
Proceeds from convertible grant agreement	0	750
Net cash provided by financing activities	153	9,740
Effect of exchange rate changes on cash, cash equivalents and restricted cash	-4	-25
Net (decrease) increase in cash, cash equivalents and restricted cash	-9,769	-20,644
Cash and cash equivalents at beginning of period	168,729	-
Cash and cash equivalents at end of period	138,316	-

Unit: Thousand (K) dollars